Lewis F A, Stirewalt M
Am J Trop Med Hyg. 1985 Mar;34(2):341-5. doi: 10.4269/ajtmh.1985.34.341.
Experiments were conducted to determine the effect of anti-schistosomal vaccine exposure on the level of pre-existing resistance in mice with a bisexual Schistosoma mansoni infection. C57BL/6 mice with light S. mansoni infections of 8 weeks duration were injected with 10 Krad-irradiated, cryopreserved and thawed schistosomules. Four weeks later the mice were exposed to normal cercariae, and adult worms collected by perfusion 6 weeks post-challenge. In 4 experiments, the baseline levels of resistance in infected mice ranged from 19% to 50% reduction in challenge worm burden (mean of 36%). Although vaccine administration slightly raised the overall level of resistance in infected mice (mean of 49%), in only 1 experiment was the increase over that in infected mice statistically significant. The levels of resistance attributed to the patent infection and vaccine exposure were not additive. Vaccine exposure had no effect on recovery of the adult worms of the primary infection.
开展实验以确定抗血吸虫疫苗暴露对感染曼氏血吸虫的小鼠体内预先存在的抵抗力水平的影响。对感染曼氏血吸虫8周且感染程度较轻的C57BL/6小鼠注射10千拉德辐照、冷冻保存并解冻的血吸虫尾蚴。四周后,让这些小鼠接触正常尾蚴,并在攻击后6周通过灌注收集成虫。在4项实验中,感染小鼠的基线抵抗力水平使攻击虫负荷降低了19%至50%(平均为36%)。虽然接种疫苗略微提高了感染小鼠的总体抵抗力水平(平均为49%),但只有1项实验中,感染小鼠的这种增加具有统计学意义。归因于显性感染和疫苗暴露的抵抗力水平并非相加关系。疫苗暴露对原发性感染成虫的恢复没有影响。